PARP2 targeted therapeutic (Eluciderm)

N/A

Report date: 2025/06/11 10:26:31
NME

Base Information

Drug NamePARP2 targeted therapeutic (Eluciderm)
Drug Alias Namenovel compound 6 (Eluciderm)
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) Polymerase 2 inhibitors
TargetsPoly (ADP-Ribose) Polymerase 2
Therapy Area/IndicationsSkin NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEluciderm Inc
China Registration ClassN/A

Develop Information

Active CompaniesEluciderm Inc
Inactive CompaniesN/A
Active IndicationsSkin NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A